Hlavní tematické sekce
- LEUKEMIA + HSC BIOLOGY AND NOVEL THERAPEUTIC APPROACHES FOR CML ERADICATION
- GENETICS, BIOLOGY AND POSSIBLE THERAPIES FOR CML IN BLASTIC TRANSFORMATION
- ALTERNATIVE AVENUES TO TARGET CML STEM/PROGENITOR CELLS
- GENOMIC INSTABILITY AND GENETICS OF CML
- ABL TYROSINE KINASE INHIBITORS (1): BIOLOGY AND RESISTANCE
- IMMUNOLOGICAL TARGETS AND MONITORING AT LOW LEUKEMIA LEVEL
- ABL TYROSINE KINASE INHIBITORS (2): BIOLOGY AND RESISTANCE
- CML CLINICAL ASPECTS AND NEW TRIALS
- MINI-DEBATES: TOPICAL BIOLOGICAL QUESTIONS
- MINI-DEBATE: TOPICAL CLINICAL QUESTIONS
Aktivní účast
- Abstrakta do 10. července 2011
Registrace
Kontakt: marjolaine.silva@esh.org
Web: http://www.esh.org...iology-and-therapy/
- Přidat do kalendáře: 2011-09-22 00:00:00 2011-09-25 23:59:59 Europe/Prague ESH-ICMLF 13th International Conference Chronic Myeloid Leukemia: Biological Basis of Therapy Hlavní tematické sekce LEUKEMIA + HSC BIOLOGY AND NOVEL THERAPEUTIC APPROACHES FOR CML ERADICATION GENETICS, BIOLOGY AND POSSIBLE THERAPIES FOR CML IN BLASTIC TRANSFORMATION ALTERNATIVE AVENUES TO TARGET CML STEM/PROGENITOR CELLS GENOMIC INSTABILITY AND GENETICS OF CML ABL TYROSINE KINASE INHIBITORS (1): BIOLOGY AND RESISTANCE IMMUNOLOGICAL TARGETS AND MONITORING AT LOW LEUKEMIA LEVEL ABL TYROSINE KINASE INHIBITORS (2): BIOLOGY AND RESISTANCE CML CLINICAL ASPECTS AND NEW TRIALS MINI-DEBATES: TOPICAL BIOLOGICAL QUESTIONS MINI-DEBATE: TOPICAL CLINICAL QUESTIONS Estoril Congress Center, Estoril, Portugal